New Zealand markets open in 1 hour 13 minutes

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
243.58+6.80 (+2.87%)
At close: 04:00PM EDT
243.58 0.00 (0.00%)
After hours: 04:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close236.78
Bid243.14 x 1000
Ask243.45 x 800
Day's range239.46 - 243.64
52-week range189.40 - 301.34
Avg. volume571,258
Market cap35.632B
Beta (5Y monthly)0.47
PE ratio (TTM)45.96
Earnings dateN/A
Forward dividend & yield1.68 (0.69%)
Ex-dividend date11 May 2022
1y target estN/A
  • GlobeNewswire

    ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio

    Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care gap and providing alternative to prevailing drug therapy mementor to be integrated into ResMed in Germany as a separate business segment and will serve as a platform for further developments in the field of digital health MARTINSRIED, Germany and LEIPZIG, Germany, Aug. 02, 2022 (GLOBE NEWSWIRE) -- R

  • GlobeNewswire

    ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022

    SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: • Location:•

  • GlobeNewswire

    ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care

    Lucile Blaise, President, Sleep & Respiratory Care, ResMed Lucile Blaise, President, Sleep & Respiratory Care, ResMed Blaise is a medtech industry thought leader with over 25 years’ experienceA board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech associationPromotion effective July 1 SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective Ju